MONTREAL, CANADA--(Marketwired - Oct 8, 2015) - CAE Healthcare today announced it is delivering a next generation simulation-based solution to Abiomed for its Impella® heart pump training programs.

WASHINGTON, DISTRICT OF COLUMBIA--(Marketwired - Sep 13, 2014) - (CAE)(CAE.TO) - CAE Healthcare today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2014, the world's largest ...

BOSTON--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) will highlight how Impella heart pumps help heart teams achieve more complete high-risk revascularization and heart recovery in the catheterization lab ...

According to the World Health Organization, diseases of the circulatory system, including heart disease such as heart attacks, are still among the most common causes of death worldwide. Recovering the ...

Heart support tech company Abiomed ($ABMD) beat analyst earnings and revenue estimates as well as raised its fiscal 2016 guidance on its latest earnings call. All of ...

DANVERS, Mass. – October 24, 2024 – Novel data on the benefits of Impella ® heart pump technology in high-risk percutaneous coronary intervention (PCI) and cardiogenic shock will be presented during ...